Video Consultation Model Aids Mental Health in Primary Care Patients
WEDNESDAY, Oct. 2, 2024 -- The PROVIDE model of video consultation leads to a decrease in depressive and anxiety symptoms among primary care patients, according to a study published online Sept. 25 in The BMJ.
Markus W. Haun, M.D., from Heidelberg University in Germany, and colleagues evaluated whether an integrated mental health video consultation approach (PROVIDE model) can improve symptoms compared to usual care in adults with depression and anxiety disorders attending primary care. The analysis included 376 adults (aged 18 to 81 years) randomly assigned to the PROVIDE model or usual care.
The researchers found that compared with usual care, the PROVIDE intervention led to improvements in severity of depressive and anxiety symptoms (adjusted mean change difference in the Patient Health Questionnaire Anxiety and Depression Scale score, −2.4 points) at six months. At 12 months, the effects were sustained (−2.9 points).
"Through relatively low intensity treatment, the PROVIDE model led to a decrease in depressive and anxiety symptoms with small effects in the short and long term," the authors write. "Depression and anxiety disorders are prevalent and therefore the small effect might cumulatively impact on population health in this population."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
No Adverse Neurodevelopmental Effects Seen From Inhaled Anesthesia in Children Under 2
THURSDAY, Sept. 11, 2025 -- For children younger than 2 years undergoing surgery, no adverse neurodevelopmental effects are seen with the addition of dexmedetomidine and...
Dementia Odds Significantly Increase With More Psychiatric Comorbidities
WEDNESDAY, Sept. 10, 2025 -- Dementia odds significantly increase with the number of psychiatric comorbidities, according to a study published online Sept. 9 in BMJ Mental...
Single Psychedelic Dose Reduces Symptoms of Generalized Anxiety Disorder
WEDNESDAY, Sept. 10, 2025 -- A single dose of a pharmaceutical formulation of LSD provides significant relief for patients with moderate-to-severe generalized anxiety disorder...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.